IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (8)
Guggenheim
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 | Xilio Therapeut | Health-Care | 16 | 7 | MS | COWN | GGNH | 19.2% | 0% | ||
| Jun 17 | Verve Therapeut | Health-Care | 19 | 14 | JPM | GGNH | WB | 29.8% | 68% | ||
| May 6 | Valneva SE | Health-Care | 26.4 | 3 | GS | JEFF | GGNH | 16.2% | 7.3% | ||
| Apr 23 | Impel NeuroPhar | Health-Care | 15 | 5 | COWN | GGNH | 56.2% | 0% | |||
| Mar 12 | Prometheus Bios | Health-Care | 19 | 10 | CS | Stifel | GGNH | 39.2% | 33.1% | ||
| Mar 12 | JOANN Inc. | Capital-Goods | 12 | 10 | BAML | CS | GGNH | 48.8% | 2.1% | ||
| Feb 5 | Bolt Biotherape | Health-Care | 20 | 11 | MS | Stifel | GGNH | 60.1% | 60.8% | ||
| Jan 27 | Shoals Technolo | Capital-Goods | 25 | 77 | GS | JPM | GGNH | 9.6% | 32% | ||
*
Lead manager or one of top three managers in an underwriting team.